Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiu-Wu Pan

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Oncology Reports|December 23, 2022
ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironmentWei-Jie Chen, Wei Yang, Min Gong, et al.
Cancer Letters|May 20, 2024
Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progressionWen-Jin Chen, Xiu-Wu Pan, Xu Song, et al.
International Journal of Biological Sciences|November 9, 2020
Identification of a novel cancer stem cell subpopulation that promotes progression of human fatal renal cell carcinoma by single-cell RNA-seq analysisXiu-Wu Pan, Hao Zhang, Da Xu, et al.
International Journal of Oncology|May 24, 2017
Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cellsMing Chen, Jian-Min Lv, Jian-Qing Ye, et al.
Oncotarget|March 10, 2016
Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongationYi Huang, Xiu-Wu Pan, Lin Li, et al.
International Journal of Oncology|April 2, 2016
EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signalingXiu-Wu Pan, Lu Chen, Yi Hong, et al.
Ebiomedicine|December 19, 2018
Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinomaChao Wang, Yan Li, Chuan-Min Chu, et al.
Cell Death & Disease|July 27, 2024
DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathwaySi-Chen Di, Wen-Jin Chen, Wei Yang, et al.
Cell Death & Disease|January 12, 2022
Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics studyWen-Jin Chen, Hao Cao, Jian-Wei Cao, et al.
International Journal of Oncology|September 27, 2016
SMC1A promotes growth and migration of prostate cancer in vitro and in vivoXiu-Wu Pan, Si-Shun Gan, Jian-Qing Ye, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Oncology Reports|December 23, 2022
ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironmentWei-Jie Chen, Wei Yang, Min Gong, et al.
Cancer Letters|May 20, 2024
Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progressionWen-Jin Chen, Xiu-Wu Pan, Xu Song, et al.
International Journal of Biological Sciences|November 9, 2020
Identification of a novel cancer stem cell subpopulation that promotes progression of human fatal renal cell carcinoma by single-cell RNA-seq analysisXiu-Wu Pan, Hao Zhang, Da Xu, et al.
International Journal of Oncology|May 24, 2017
Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cellsMing Chen, Jian-Min Lv, Jian-Qing Ye, et al.
Oncotarget|March 10, 2016
Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongationYi Huang, Xiu-Wu Pan, Lin Li, et al.
International Journal of Oncology|April 2, 2016
EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signalingXiu-Wu Pan, Lu Chen, Yi Hong, et al.
Ebiomedicine|December 19, 2018
Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinomaChao Wang, Yan Li, Chuan-Min Chu, et al.
Cell Death & Disease|July 27, 2024
DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathwaySi-Chen Di, Wen-Jin Chen, Wei Yang, et al.
Cell Death & Disease|January 12, 2022
Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics studyWen-Jin Chen, Hao Cao, Jian-Wei Cao, et al.
International Journal of Oncology|September 27, 2016
SMC1A promotes growth and migration of prostate cancer in vitro and in vivoXiu-Wu Pan, Si-Shun Gan, Jian-Qing Ye, et al.
Pageof 4